HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immune response capacity after human splenic autotransplantation: restoration of response to individual pneumococcal vaccine subtypes.

AbstractOBJECTIVE:
To evaluate features of general immune function, in particular the restoration of the humoral immune response to pneumococcal capsular polysaccharides, in humans undergoing a spleen autotransplantation after splenectomy because of trauma.
SUMMARY BACKGROUND DATA:
After splenectomy, patients have an increased risk of overwhelming infection or sepsis involving encapsulated bacteria such as pneumococci. The value of human spleen autotransplantation after splenectomy because of trauma has long been questioned. Mononuclear phagocyte system function appeared to be similar to that in splenectomized persons. The presence of specific antipneumococcal antibodies would allow other parts of the mononuclear phagocyte system, such as those in the liver, to phagocytose opsonized bacteria.
METHODS:
Ten consecutive patients undergoing splenectomy followed by autotransplantation were compared with the next 14 consecutive patients undergoing splenectomy alone. After a minimum of 6 months, the patients were vaccinated with 23-valent pneumococcal vaccine. Blood samples were taken at the time of vaccination and after 3 and 6 weeks for antipneumococcal capsular polysaccharides IgM and IgG enzyme-linked immunosorbent assay against types 3, 4, 6, 9, 14, and 23. Splenic regrowth was evaluated by scintigraphy.
RESULTS:
Surprisingly, several of the nonautotransplanted patients showed scintigraphic activity, indicating the presence of either accessory spleens or traumatic seeding (splenosis). Significant antibody titer increases (more than twofold) were found for both IgM and IgG in the autotransplanted patients. Splenectomized-only patients showed no significant increase in Ig levels in patients without splenic regrowth and partial improvement in patients with splenosis/accessory spleens.
CONCLUSIONS:
Considering this significant antipneumococcal antibody increase, spleen autotransplants can be expected to permit an adequate humoral response to pneumococcal infections and presumably also to other TI-2 antigens, and to protect against overwhelming postsplenectomy infection or sepsis.
AuthorsR Leemans, W Manson, J A Snijder, J W Smit, H J Klasen, T H The, W Timens
JournalAnnals of surgery (Ann Surg) Vol. 229 Issue 2 Pg. 279-85 (Feb 1999) ISSN: 0003-4932 [Print] United States
PMID10024111 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antibodies, Bacterial
  • Bacterial Vaccines
  • Pneumococcal Vaccines
Topics
  • Adolescent
  • Adult
  • Antibodies, Bacterial (blood)
  • Bacterial Vaccines (immunology)
  • Humans
  • Male
  • Middle Aged
  • Pneumococcal Vaccines
  • Spleen (transplantation)
  • Splenectomy
  • Streptococcus pneumoniae (classification, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: